Astellas & CLINO Announces License Agreement To Develop & Commercialize Gene Therapy To Treat Retinitis Pigmentosa
Astella and CLINO have entered into a license agreement for the development and commercialization of gene therapy to treat Retinitis Pigmentosa.
Read More